bevacizumab,cetuximab
roche,eli lilly
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'cetuximab', 'fire-4']
 fire-4 study: influence of baseline liquid biopsy on efficacy of folfiri/cetuximab tissue ras-wt #mcrc #asco23 phs-iii, 673 pts lb detected ras mut in 13% of pts deemed raswt based on tissue with expectable poor outcome supports use of lb 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology